Jianqiang Li
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T.
Journal: Journal for immunotherapy of cancer
Published: January 29, 2026
Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy.
Journal: American journal of hematology
Published: August 14, 2023
Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma.
Journal: Cells
Published: October 26, 2022
Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
Journal: Journal of translational medicine
Published: September 29, 2022
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.
Journal: Cancer immunology, immunotherapy : CII
Published: January 27, 2021
Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo.
Journal: Molecular therapy. Methods & clinical development
Published: November 15, 2020
Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.
Journal: Annals of translational medicine
Published: November 04, 2020
Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia.
Journal: Hematological oncology
Published: January 15, 2019
Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation treated by CAR T-cell therapy: a case report.
Journal: OncoTargets and therapy
Published: October 16, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026